These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1449037)

  • 1. Cytologic and immunocytochemical studies of cerebrospinal fluid in meningeal sarcoidosis. A case report.
    Li CY; Yam LT
    Acta Cytol; 1992; 36(6):963-7. PubMed ID: 1449037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity.
    Wengert O; Rothenfusser-Korber E; Vollrath B; Bohner G; Scheibe F; Otto C; Hofmann J; Angstwurm K; Ruprecht K
    J Neurol Sci; 2013 Dec; 335(1-2):124-30. PubMed ID: 24071064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic pitfalls in cerebrospinal fluid cytology.
    Takeda M; King DE; Choi HY; Gomi K; Lang WR
    Acta Cytol; 1981; 25(3):245-50. PubMed ID: 6942615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of T lymphocytes in human blood and cerebrospinal fluid with Helix pomatia A hemagglutinin.
    Schädlich HJ; Bliersbach Y; Weidenhammer J
    Acta Cytol; 1984; 28(4):411-3. PubMed ID: 6331702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic analysis of cerebrospinal fluid cells over the course of Lyme meningoradiculitis.
    Sindern E; Malin JP
    Acta Cytol; 1995; 39(1):73-5. PubMed ID: 7847012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.
    Chazal T; Costopoulos M; Maillart E; Fleury C; Psimaras D; Legendre P; Pineton de Chambrun M; Haroche J; Lubetzki C; Amoura Z; Legarff-Tavernier M; Cohen Aubart F
    Eur J Neurol; 2019 Oct; 26(10):1274-1280. PubMed ID: 31021023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessment of cytologic values in canine cerebrospinal fluid by use of cytocentrifugation.
    Christopher MM; Perman V; Hardy RM
    J Am Vet Med Assoc; 1988 Jun; 192(12):1726-9. PubMed ID: 3410789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunoregulatory mechanisms in the central nervous system: characterization of noninflammatory and inflammatory cerebrospinal fluid lymphocytes.
    Matsui M; Mori KJ; Saida T
    Ann Neurol; 1990 Jun; 27(6):647-51. PubMed ID: 2360801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytodiagnosis in the cerebrospinal fluid with special reference to illness course phases in diseases of the central nervous system].
    Olischer RM
    Psychiatr Neurol Med Psychol (Leipz); 1988 Oct; 40(10):609-16. PubMed ID: 3237867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis.
    Khoury J; Wellik KE; Demaerschalk BM; Wingerchuk DM
    Neurologist; 2009 Mar; 15(2):108-11. PubMed ID: 19276791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of interferon-gamma and IL-6 producing cells in cerebrospinal fluid cells in the central nervous system infectious diseases using immunocytochemistry].
    Nakamura S; Nagano I; Yoshioka M; Onodera J; Kogure K
    Rinsho Shinkeigaku; 1992 Feb; 32(2):143-7. PubMed ID: 1611772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid cytology in histiocytic proliferative disorders.
    Hamilton SR; Gupta PK; Marshall ME; Donovan PA; Wingard JR; Zaatari GS
    Acta Cytol; 1982; 26(1):22-8. PubMed ID: 6175126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurosarcoidosis: cerebrospinal fluid lymphocyte subpopulations.
    Stern BJ; Griffin DE; Luke RA; Krumholz A; Johns CJ
    Neurology; 1987 May; 37(5):878-81. PubMed ID: 2952900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia.
    Uozumi K; Ishitsuka K; Ohno N; Nakahara K; Utsunomiya A; Hanada S; Arima T
    Leuk Lymphoma; 1995 Nov; 19(5-6):437-45. PubMed ID: 8590844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
    Subirá D; Castañón S; Aceituno E; Hernández J; Jiménez-Garófano C; Jiménez A; Jiménez AM; Román A; Orfao A
    Am J Clin Pathol; 2002 Jun; 117(6):952-8. PubMed ID: 12047148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the cerebrospinal fluid in leukemic meningosis].
    Wieczorek V; Zintl F; Stahl J; Aurich G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(4):357-65. PubMed ID: 4107569
    [No Abstract]   [Full Text] [Related]  

  • 17. [The cerebrospinal fluid and neurocysticercosis: evolutional aspects of the cellular inflammatory response].
    Machado LR
    Arq Neuropsiquiatr; 1987 Dec; 45(4):353-63. PubMed ID: 3449020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic features of cerebrospinal fluid in Lyme disease.
    Razavi-Encha F; Fleury-Feith J; Gherardi R; Bernaudin JF
    Acta Cytol; 1987; 31(4):439-40. PubMed ID: 3604539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport and production of cerebrospinal fluid (CSF) change in aging humans under normal and diseased conditions.
    Kleine TO; Hackler R; Lütcke A; Dauch W; Zöfel P
    Z Gerontol; 1993; 26(4):251-5. PubMed ID: 8212795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system.
    Chang H; Bartlett ES; Patterson B; Chen CI; Yi QL
    Br J Haematol; 2005 May; 129(4):539-41. PubMed ID: 15877737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.